PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-17.37%
Negative revenue growth while MCHP stands at 10.82%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-66.29%
Negative gross profit growth while MCHP is at 15.09%. Joel Greenblatt would examine cost competitiveness or demand decline.
-101.44%
Negative EBIT growth while MCHP is at 140.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-101.44%
Negative operating income growth while MCHP is at 132.00%. Joel Greenblatt would press for urgent turnaround measures.
-63.79%
Negative net income growth while MCHP stands at 87.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-65.00%
Negative EPS growth while MCHP is at 70.34%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-65.00%
Negative diluted EPS growth while MCHP is at 70.34%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-2.12%
Share reduction while MCHP is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.12%
Reduced diluted shares while MCHP is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
3.02%
Dividend growth under 50% of MCHP's 10.17%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-74.43%
Negative OCF growth while MCHP is at 33.85%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-1004.76%
Negative FCF growth while MCHP is at 34.43%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
24.33%
10Y revenue/share CAGR under 50% of MCHP's 51.09%. Michael Burry would suspect a lasting competitive disadvantage.
24.33%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
13.75%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
192.70%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
192.70%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
-83.61%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.60%
3Y dividend/share CAGR similar to MCHP's 81.65%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-2.85%
Firm’s AR is declining while MCHP shows 10.99%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.52%
We show growth while MCHP is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.34%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.80%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
-3.06%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
7.50%
SG&A growth well above MCHP's 4.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.